Recruiting studies: Warm Antibody Autoimmune Hemolytic Anemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (w
Phase 2 · 25 location(s) · Novartis Pharmaceuticals · NCT07039422 IASO-782 in Autoimmune Hematological Diseases
Phase 1 · 2 location(s) · Shanghai IASO Biotechnology Co., Ltd · NCT06534021 Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Diso
Phase 2 · 40 location(s) · Incyte Corporation · NCT07104565

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.